Regarding NAN:
It is an interesting concept, and appears to have some institutional support. I first heard about this several weeks ago. However, ultrasound technology has been used as a point of care device in various subspecialties for over ten years. Initially used for diagnosis, and more recently for interventional procedures. Although novel, it is not clear there is a need, or any significant need, for this in current medical practice.
(Disclosure: this is the opinion of a specialist who has published and presented locally and internationally on ultrasound-related applications.)
- Forums
- ASX - By Stock
- SRX
- SRX vs BTG
SRX vs BTG, page-22
Featured News
Add SRX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online